Their physical and emotional health had withered in the pandemic year. But reentry into post-vaccination life made for tricky choices, too.
After several days of more than peak traffic over the last few weeks, Tybee Island is adding lifeguards and making traffic changes.
White evangelical Christians are one of the most vaccine-hesitant groups in the United States. They're also among the largest religious groups, and their reluctance poses a public health challenge.
A viral TikTok makes vaccine science understandable and pretty funny (it's a horror film parody). NPR caught up with creator and star Vick Krishna — tech expert by day, videographer by night.
The Tuskegee syphilis study is often cited as a reason why Black Americans might hesitate on the COVID-19 vaccine. But many say it's current racism in health care and Tuskegee is used as an excuse.
People who've had dose 1 are wondering ... can I have a few drinks before dose 2 or will that muck things up? Also: Do you really understand the concept of "vaccine efficacy"? It's complicated!
The third COVID-19 vaccine authorized for use in the U.S. requires one shot instead of two, and works a slightly different way from the others. Here's what we know about its safety and effectiveness.
The House Select Subcommittee on the Coronavirus Crisis is investigating after NPR reported that the boutique health care provider allowed ineligible patients to skip the COVID-19 vaccine line.
Concierge health care provider One Medical has been allowing ineligible people to receive COVID-19 vaccines. Staff questioned what they saw as inappropriate, internal documents obtained by NPR show.
The director of the Florida Department of Health in Orange County said the women disguised themselves with bonnets, gloves and glasses. It is not known how they managed to get their first doses.
The Rosebud Sioux Tribe is vaccinating its community at rates faster than the rest of South Dakota. That mirrors a trend in Indian Country, which has been hard-hit by the coronavirus.
A small study in South Africa has raised concerns about the effectiveness of the AstraZeneca vaccine, particularly in fighting virus variants.
A study raised concerns about its effectiveness against the coronavirus variant sweeping through the country — although the data is too preliminary for definitive conclusions.
There are those among us who are needle-phobic. So what's the verdict on the vaccine? And are there any techniques for easing any potential pain?
European Commission President Ursula von der Leyen announced Sunday that AstraZeneca would also deliver the vaccines one week earlier than originally scheduled.